SDZ GLI 328

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameSDZ GLI 328
Drug Alias NameGLI 328HS thymidine kinase gene therapy - Genetic TherapyGLI-328
ClassificationCell and gene therapy > Cell therapyCell and gene therapy > Gene therapy
Mechanisms of ActionGene transference
TargetsNot applicable
Therapy Area/IndicationsGlioblastomaGlioma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGenetic Therapy Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGenetic Therapy Inc
Active IndicationsN/A
Inactive IndicationsGlioblastomaGlioma

Other Information

ATC CodeN/A
Related LinksN/A